Discuss This Drug

Ribavirinum

CHEBI:CHEBI_750213

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20251231
route
ORAL
nui
N0000175466
pharm_class
Nucleoside Analog Antiviral [EPC]
product_type
HUMAN OTC DRUG
marketing_category
UNAPPROVED HOMEOPATHIC
dosage_form
PELLET
active_ingredient_strength
1 [hp_Q]/1
active_ingredient_name
RIBAVIRIN
unii
49717AWG6K
pharm_class_epc
Nucleoside Analog Antiviral [EPC]
marketing_start_date
20231012
package_marketing_start_date
20231012
labeler_name
Hahnemann Laboratories, INC.
manufacturer_name
Hahnemann Laboratories, INC.
generic_name
Ribavirinum
brand_name
Ribavirinum
brand_name_base
Ribavirinum
product_ndc
37662-4141
spl_id
078e2ef1-2e1e-f8c3-e063-6394a90a145e
package_ndc
37662-4141-4
package_description
10000 PELLET in 1 BOTTLE, GLASS (37662-4141-4)
spl_set_id
078e2ef1-2e1d-f8c3-e063-6394a90a145e
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class